1446263-38-2

Linagliptin-5 Linagliptin iMpurity E Linagliptin Impurity 27 Linagliptin Regio-isomer (S)-tert-butyl (1-(7-(but-2-yn-1-yl) (R)-7-(but-2-yn-1-yl)-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-3,7-dihydro-1H-purine-2,6-dione (R)-7-(but-2-ynyl)-3-Methyl-1-((4-Methylquinazolin-2-yl)Methyl)-8-(piperidin-3-ylaMino)-1H-purine-2,6(3H,7H)-dione (R)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-8-(piperidin-3-ylamino)-3,7-dihydro-1H-purine-2,6-dione 1H-Purine-2,6-dione, 7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3R)-3-piperidinylamino]- tert-butyl (R)-(1-(3-methyl-1,7-bis((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate Linagliptin impurity EQ: What is Linagliptin impurity E Q: What is the CAS Number of Linagliptin impurity E Q: What is the storage condition of Linagliptin impurity E Linagliptin impurity 2/Tert-butyl (S)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate Linagliptin impurity 10/tert-butyl (S)-(1-(7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate